Efficacy and safety of biosimilar infliximab in bio-naïve patients with Crohn's disease.
Oike T, Akizue N, Ohta Y, Koseki H, Saito M, Yokoyama Y, Imai Y, Taida T, Okimoto K, Saito K, Ogasawara S, Matsumura T, Nakagawa T, Arai M, Katsuno T, Fukuda Y, Kitsukawa Y, Kato J, Kato N.
Oike T, et al.
Arab J Gastroenterol. 2024 May 6:S1687-1979(24)00036-4. doi: 10.1016/j.ajg.2024.03.006. Online ahead of print.
Arab J Gastroenterol. 2024.
PMID: 38714472